Relmada Therapeutics Inc

NASDAQ:RLMD   12:51:03 PM EDT
18.93
-0.38 (-1.97%)
Earnings Announcements

Relmada Therapeutics Provides Corporate Update And Reports First Quarter 2022 Financial Results

Published: 05/05/2022 20:07 GMT
Relmada Therapeutics Inc (RLMD) - Relmada Therapeutics Provides Corporate Update and Reports First Quarter 2022 Financial Results.
Q1 Loss per Share $1.40.
Q1 Earnings per Share View $-1.27 -- Refinitiv Ibes Data (analyst estimates).
Revenue is expected to be $0 Million
Adjusted EPS is expected to be -$1.27

Next Quarter Revenue Guidance is expected to be $0 Million
Next Quarter EPS Guidance is expected to be -$1.27

More details on our Analysts Page.